Exportar registro bibliográfico


Metrics:

Immunohistochemical assessment of the expression of biliary transportation proteins MRP2 and MRP3 in hepatocellular carcinoma and in cholangiocarcinoma (2019)

  • Authors:
  • USP affiliated authors: SILVA, ALOISIO SOUZA FELIPE DA - HU ; MELLO, EVANDRO SOBROZA DE - FM ; ALVES, VENANCIO AVANCINI FERREIRA - FM
  • Unidades: HU; FM
  • DOI: 10.1007/s12253-018-0386-8
  • Subjects: CARCINOMA HEPATOCELULAR; IMUNOHISTOQUÍMICA
  • Language: Inglês
  • Imprenta:
  • Source:
  • PrivadoAcesso à fonteDOI
    Informações sobre o DOI: 10.1007/s12253-018-0386-8 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed

    Download do texto completo

    Tipo Nome Link
    Privado2973476.pdf
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      CIRQUEIRA, Cinthya Santos; FELIPE-SILVA, Aloísio Sousa; WAKAMATSU, Alda; et al. Immunohistochemical assessment of the expression of biliary transportation proteins MRP2 and MRP3 in hepatocellular carcinoma and in cholangiocarcinoma. Pathology and Oncology Research, Budapeste, Springer, v. 25, n. 4, p. 1363-1371, 2019. Disponível em: < https://link.springer.com/content/pdf/10.1007%2Fs12253-018-0386-8.pdf > DOI: 10.1007/s12253-018-0386-8.
    • APA

      Cirqueira, C. S., Felipe-Silva, A. S., Wakamatsu, A., Marins, L. V., Rocha, E. C., Mello, E. S. de, & Alves, V. A. F. (2019). Immunohistochemical assessment of the expression of biliary transportation proteins MRP2 and MRP3 in hepatocellular carcinoma and in cholangiocarcinoma. Pathology and Oncology Research, 25( 4), 1363-1371. doi:10.1007/s12253-018-0386-8
    • NLM

      Cirqueira CS, Felipe-Silva AS, Wakamatsu A, Marins LV, Rocha EC, Mello ES de, Alves VAF. Immunohistochemical assessment of the expression of biliary transportation proteins MRP2 and MRP3 in hepatocellular carcinoma and in cholangiocarcinoma [Internet]. Pathology and Oncology Research. 2019 ; 25( 4): 1363-1371.Available from: https://link.springer.com/content/pdf/10.1007%2Fs12253-018-0386-8.pdf
    • Vancouver

      Cirqueira CS, Felipe-Silva AS, Wakamatsu A, Marins LV, Rocha EC, Mello ES de, Alves VAF. Immunohistochemical assessment of the expression of biliary transportation proteins MRP2 and MRP3 in hepatocellular carcinoma and in cholangiocarcinoma [Internet]. Pathology and Oncology Research. 2019 ; 25( 4): 1363-1371.Available from: https://link.springer.com/content/pdf/10.1007%2Fs12253-018-0386-8.pdf

    Referências citadas na obra
    Vasiliou V, Vasiliou K, Nebert DW (2009) Human ATP-binding cassette (ABC) transporter family. Hum Genomics 3:281–290. https://doi.org/10.1186/1479-7364-3-3-281
    Stefková J, Poledne R, Hubácek JA (2004) ATP-binding cassette (ABC) transporters in human metabolism and diseases. Physiol Res 53(3):235–243
    Tarling EJ, de Aguiar Vallim TQ, Edwards PA (2013) Role of ABC transporters in lipid transport and human disease. Trends Endocrinol Metab 24(7):342–350. https://doi.org/10.1016/j.tem.2013.01.006
    Lagana SM, Salomao M, Remotti HE, Knisely AS, Moreira RK (2015) Bile salt export pump: a sensitive and specific immunohistochemical marker of hepatocellular carcinoma. Histopathology 66(4):598–602. https://doi.org/10.1111/his.12601
    Nguyen T, Phillips D, Jain D, Torbenson M, Wu T-T, Yeh MM et al (2015) Comparison of 5 immunohistochemical markers of hepatocellular differentiation for the diagnosis of hepatocellular carcinoma. Arch Pathol Lab Med 139(8):1028–1034. https://doi.org/10.5858/arpa.2014-0479-OA
    Fujikura K, Yamasaki T, Otani K, Kanzawa M, Fukumoto T, Ku Y et al (2016) BSEP and MDR3 – useful immunohistochemical markers to discriminate hepatocellular carcinomas from intrahepatic cholangiocarcinomas and hepatoid carcinomas. Am J Surg Pathol 40(5):689–696. https://doi.org/10.1097/PAS.0000000000000585
    Trauner M, Boyer JL (2003) Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 83(2):633–671. https://doi.org/10.1152/physrev.00027.2002
    ABCC2: ATP-binding cassette, sub-family C (CFTR/MRP), member 2. [Internet]. The Human Protein Atlas. 2017. http://www.proteinatlas.org/ENSG00000023839-ABCC2/tissue . Accessed 31 Jan 2017
    Taniguchi K, Wada M, Kohno K, Nakamura T, Kawabe T, Kawakami M et al (1996) A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res 56(18):4124–4129
    Chen Z, Shi T, Zhang L, Zhu P, Deng M, Huang C et al (2016) Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: a review of the past decade. Cancer Lett 370(1):153–164. https://doi.org/10.1016/j.canlet.2015.10.010
    Nies AT, Konig J, Cui Y, Brom M, Spring H, Keppler D (2002) Structural requirements for the apical sorting of human multidrug resistance protein 2 (ABCC2). Eur J Biochem 269(7):1866–1876. https://doi.org/10.1007/s00424-006-0109-y
    Jedlitschky G, Hoffmann U, Kroemer HK (2006) Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition. Expert Opin Drug Metab Toxicol 2(3):351–366
    Alrefai WA, Gill RK (2007) Bile acid transporters: structure, function, regulation and pathophysiological implications. Pharm Res 10:1803–1823. https://doi.org/10.1517/17425255.2.3.351
    Erlinger S, Arias IM, Dhumeaux D (2014) Inherited disorders of bilirubin transport and conjugation: new insights into molecular mechanisms and consequences. Gastroenterology 146(7):1625–1638. https://doi.org/10.1053/j.gastro.2014.03.047
    Keppler D (2014) The roles of MRP2, MRP3, OATP1B1, and OATP1B3 in conjugated hyperbilirubinemia. Drug Metab Dispos 42(4):561–565. https://doi.org/10.1124/dmd.113.055772
    Kool M, van der Linden M, de Haas M, Scheffer GL, de Vree JM, Smith AJ et al (1999) MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc Natl Acad Sci U S A 96(12):6914–6919. https://doi.org/10.1073/pnas.96.12.6914
    Scheffer GL, Kool M, Heijn M, de Haas M, Pijnenborg AC, Wijnholds J et al (2000) Specific detection of multidrug resistance proteins MRP1, MRP2, MRP3, MRP5, and MDR3 P-glycoprotein with a panel of monoclonal antibodies. Cancer Res 60(18):5269–5277
    Klaassen CD, Aleksunes LM (2010) Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol Rev 62(1):1–96. https://doi.org/10.1124/pr.109.002014
    ABCC3: ATP-binding cassette, sub-family C (CFTR/MRP), member 3 [Internet]. The Human Protein Atlas. 2017. http://www.proteinatlas.org/ENSG00000108846-ABCC3/tissue . Accessed 31 Jan 2017
    ABCC3: ATP-binding cassette, sub-family C (CFTR/MRP), member 3 [Internet]. GenAtlas - Universite Paris Descartes. 2017. http://genatlas.medecine.univ-paris5.fr/fiche.php?symbol=ABCC3 . Accessed 31 Jan 2017
    König J, Rost D, Cui Y, Keppler D (1999) Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 29(4):1156–1163. https://doi.org/10.1002/hep.510290404
    Ballatori N, Hammond CL, Cunningham JB, Krance SM, Marchan R (2005) Molecular mechanisms of reduced glutathione transport: role of the MRP/CFTR/ABCC and OATP/SLC21A families of membrane proteins. Toxicol Appl Pharmacol 204(3):238–255. https://doi.org/10.1016/j.taap.2004.09.008
    Belinsky MG, Dawson PA, Shchaveleva I, Bain LJ, Wang R, Ling V et al (2005) Analysis of the in vivo functions of Mrp3. Mol Pharmacol 68(1):160–168. https://doi.org/10.1124/mol.104.010587
    Halilbasic E, Claudel T, Trauner M (2013) Bile acid transporters and regulatory nuclear receptors in the liver and beyond. J Hepatol 58(1):155–168. https://doi.org/10.1016/j.jhep.2012.08.002
    Sodani K, Patel A, Kathawala RJ, Chen Z-S (2012) Multidrug resistance associated proteins in multidrug resistance. Chin J Cancer 31(2):58–72. https://doi.org/10.5732/cjc.011.10329
    Rau S, Autschbach F, Riedel HD, Konig J, Kulaksiz H, Stiehl A et al (2008) Expression of the multidrug resistance proteins MRP2 and MRP3 in human cholangiocellular carcinomas. Eur J Clin Investig 38(2):134–142. https://doi.org/10.1111/j.1365-2362.2007.01916.x
    Tomonari T, Takeishi S, Taniguchi T, Tanaka T, Tanaka H, Fujimoto S et al (2016) MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma. Oncotarget 7(6):7207–7215. https://doi.org/10.18632/oncotarget.6889
    Zollner G, Wagner M, Fickert P, Silbert D, Fuchsbichler A, Zatloukal K et al (2005) Hepatobiliary transporter expression in human hepatocellular carcinoma. Liver Int (2):367–379. https://doi.org/10.1111/j.1478-3231.2005.01033.x
    Nies AT, König J, Pfannschmidt M, Klar E, Hofmann WJ, Keppler D (2001) Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma. Int J Cancer 94(4):492–499. https://doi.org/10.1111/j.1478-3231.2005.01033.x
    Borght VS, Libbrecht L, Blokzijl H, Faber NK, Moshage H, Aerts R et al (2005) Diagnostic and pathogenetic implications of the expression of hepatic transporters in focal lesions occurring in normal liver. J Pathol 207(4):471–482. https://doi.org/10.1002/path.1852
    Apte U, Krisnamurthy P (2010) Molecular pathology of liver diseases. In: Monga SPS (ed) Molecular pathology of liver diseases 1st edn. Springer, Boston, pp 147–164
    Korita PV, Wakai T, Shirai Y, Matsuda Y, Sakata J, Takamura M et al (2010) Multidrug resistance-associated protein 2 determines the efficacy of cisplatin in patients with hepatocellular carcinoma. Oncol Rep 4:965–972. https://doi.org/10.3892/ijmm.2012.1173
    Atilano-Roque A, Roda G, Fogueri U, Kiser JJ, Joy MS (2016) Effect of disease pathologies on transporter expression and function. J Clin Pharmacol 56(Suppl7):S205–S221. https://doi.org/10.1002/jcph.768
    Buettner S, van Vugt JLA, IJzermans J, Groot Koerkamp B (2017) Intrahepatic cholangiocarcinoma: current perspectives. Onco Targets Ther 10:1131–1142. https://doi.org/10.2147/OTT.S93629
    Nakanuma Y, Kakuda Y (2015) Pathologic classification of cholangiocarcinoma: new concepts. Best Pract Res Clin Gastroenterol 29(2):277–293. https://doi.org/10.1016/j.bpg.2015.02.006

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2020